1840
J. Huang et al.
an ODS column and preparative HPLC (MeOH–H2O, 30:70) to afford 3 (3.4 mg) and
6 (2.9 mg). Fraction E (7 g) was separated by Sephadex LH-20 column (3.0 £ 80 cm, CHCl3–
MeOH, 50:50) to afford 4 (4.1 mg) and 5 (3.2 mg).
3.3.1. 2-Methyl pyromeconic acid 3-O-b-D-glucopyranoside-60-(O-400-hydroxybenzoate) (1)
25
Colourless needles, mp 205–2078C. ½aꢀD 243 (c 0.5, MeOH). UV (MeOH) lmax (log 1): 208
(1.97), 258 (1.92) nm. IR (KBr) nmax: 3317, 1696, 1638, 1602, 1557, 1455, 1281, 1167, 1125,
1081, 848, 773, 618 cm21. HR-ESI-MS m/z: 431.0988 [M þ Na]þ (calcd for C19H20O10Na,
431.0954). 1H NMR (CD3OD, 400 MHz) d: 6.34 (1H, d, J ¼ 5.6 Hz, H-5), 7.86 (1H, d,
J ¼ 5.6 Hz, H-6), 2.29 (3H, s, H-7), 4.89 (1H, d, J ¼ 7.3 Hz, H-10), 3.43 (1H, m, H-20), 3.41 (1H,
m, H-30), 3.40 (1H, m, H-40), 3.35 (1H, m, H-50), 4.45 (1H, dd, J ¼ 11.8, 6.7 Hz, H-60a), 4.55
(1H, dd, J ¼ 11.8, 2.4 Hz, H-60b), 7.82 (2H, d, J ¼ 7.8 Hz, H-200, H-600), 6.81 (2H, d, J ¼ 7.8 Hz,
H-300, H-500). 13C NMR (CD3OD, 100 MHz) d: 143.1 (C-2), 164.5 (C-3), 176.9 (C-4), 117.2 (C-
5), 156.9 (C-6), 15.6 (C-7), 104.6 (C-10), 77.9 (C-20), 75.4 (C-30), 71.8 (C-40), 76.0 (C-50), 64.4
(C-60), 122.2 (C-100), 132.8 (C-200, C-600), 116.4 (C-300, C-500), 163.6 (C-400), 167.7 (C-700).
3.3.2. 60-O-p-Hydroxybenzoyl-gardoside (2)
25
Amorphous powder, mp 178–1808C. ½aꢀD 254 (c 0.5, MeOH). UV (MeOH) lmax (log 1): 207
(1.82), 255 (1.90) nm. IR (KBr) nmax: 3378, 1697, 1608, 1516, 1282, 1169, 1078, 1013,
1
771 cm21. HR-ESI-MS m/z: 493.1332 [M 2 H]þ (calcd for C23H25O12, 493.1346). H NMR
(CD3OD, 400 MHz) d: 5.14 (1H, d, J ¼ 5.2 Hz, H-1), 7.34 (1H, br s, H-3), 3.13 (1H, dt, J ¼ 7.6,
7.0 Hz, H-5), 1.93 (1H, m, H-6a), 1.80 (1H, dt, J ¼ 6.4, 12.8 Hz, H-6b), 4.28 (1H, m, H-7), 2.88
(1H, m, H-9), 5.15 (1H, br s, H-10a), 5.23 (1H, t, J ¼ 1.8 Hz, H-10b), 4.69 (1H, d, J ¼ 7.9 Hz, H-
10), 3.25 (1H, m, H-20), 3.41 (1H, m, H-30), 3.40 (1H, m, H-40), 3.60 (1H, m, H-50), 4.42 (1H, dd,
J ¼ 11.8, 6.7 Hz, H-60a), 4.58 (1H, dd, J ¼ 11.8, 2.4 Hz, H -60b), 7.87 (2H, d, J ¼ 7.8 Hz, H-200,
H-600), 6.81 (2H, d, J ¼ 7.8 Hz, H-300, H-500). 13C NMR (CD3OD, 100 MHz) d: 96.8 (C-1), 152.0
(C-3), 113.5 (C-4), 32.5 (C-5), 41.1 (C-6), 73.9 (C-7), 152.8 (C-8), 44.7 (C-9), 113.2 (C-10),
172.1 (C-11), 100.2 (C-10), 74.7 (C-20), 77.9 (C-30), 71.9 (C-40), 75.6 (C-50), 64.6 (C-60), 122.2
(C-100), 132.8 (C-200, C-600), 116.2 (C-300, C-500), 163.8 (C-400), 167.9 (C-700).
3.4. Acid hydrolysis and GC analysis of 1 and 2
Each solution of compounds 1 and 2 (each 1.5 mg) was hydrolysed with 1.5 mL of 2 N HCl
(CH3OH) for 3 h at 808C. The reaction mixture was dissolved in H2O and extracted with CHCl3.
The aqueous layer was concentrated and dried by N2. Then, 1 mL of dried pyridine and 2 mg of
L-cysteine methylester hydrochloride were added to the residue. The mixture was heated at 608C
for 2 h and concentrated to dryness with N2. N-(Trimethylsilyl) imidazole (0.2 mL) was added
into the mixture, and then kept at 608C for 1 h. At last, the solution was diluted with H2O (1 mL)
and extracted with hexane (1 mL). The organic layer was analysed under the following
conditions: HP-1701 (0.25 mm £ 30 m), detector: FID, column temperature: 200–2508C (58C/
min), detector temperature: 2808C, injector temperature: 2508C and carried gas: N2. The
standard D-glucose and L-glucose were subjected to the same reaction and GC analysis under
the above conditions [tR (min): 30.63 (D-glucose), tR (min): 33.23 (L-glucose)]. As a result,
D-glucose [tR (min): 30.68–30.79] was detected from the hydrolysates of 1 and 2, respectively.